OI
LLY icon

Oakbrook Investments’s Eli Lilly LLY Stock Holding History

Oakbrook Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-43,650
Closed -$4.88M – 610
2019
Q3 		$4.88M Sell
43,650
-3,625
-8% -$404K 0.32% 50
2019
Q2 		$5.24M Buy
47,275
+41,375
+701% +$4.87M 0.31% 54
2019
Q1 		$766K Sell
5,900
-900
-13% -$109K 0.05% 300
2018
Q4 		$787K Buy
6,800
+3,075
+83% +$343K 0.05% 272
2018
Q3 		$400K Sell
3,725
-33,700
-90% -$3.37M 0.02% 486
2018
Q2 		$3.19M Buy
+37,425
New +$3.07M 0.2% 82
2018
Q1 		– Sell
-43,950
Closed -$3.71M – 600
2017
Q4 		$3.71M Buy
+43,950
New +$3.74M 0.24% 68
2017
Q3 		– Sell
-73,400
Closed -$6.04M – 580
2017
Q2 		$6.04M Sell
73,400
-7,250
-9% -$591K 0.4% 50
2017
Q1 		$6.78M Sell
80,650
-6,330
-7% -$507K 0.44% 48
2016
Q4 		$6.4M Sell
86,980
-13,000
-13% -$968K 0.42% 50
2016
Q3 		$8.02M Sell
99,980
-3,650
-4% -$292K 0.49% 50
2016
Q2 		$8.16M Buy
103,630
+5,100
+5% +$384K 0.45% 51
2016
Q1 		$7.09M Buy
98,530
+2,950
+3% +$223K 0.46% 51
2015
Q4 		$8.05M Sell
95,580
-5,120
-5% -$425K 0.51% 50
2015
Q3 		$8.43M Buy
100,700
+91,800
+1,031% +$7.75M 0.55% 45
2015
Q2 		$743K Buy
8,900
+4,550
+105% +$347K 0.05% 305
2015
Q1 		$316K Sell
4,350
-5,550
-56% -$395K 0.02% 457
2014
Q4 		$683K Buy
9,900
+5,500
+125% +$371K 0.04% 326
2014
Q3 		$285K Sell
4,400
-161,600
-97% -$10.2M 0.02% 449
2014
Q2 		$10.3M Buy
+166,000
New +$9.9M 0.31% 84
2013
Q4 		– Sell
-204,087
Closed -$10.3M – 617
2013
Q3 		$10.3M Sell
204,087
-7,250
-3% -$380K 0.3% 86
2013
Q2 		$10.4M Buy
+211,337
New +$11.5M 0.3% 85

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Oakbrook Investments's LLY Position: Q4 2019 in Review

Oakbrook Investments sold out of Eli Lilly (LLY) in Q4 2019, closing a stake of 43,650 shares — an estimated $4.88M sold.

Oakbrook Investments first reported a position in LLY in Q2 2013 and held it in 22 quarters. The position peaked at $10.4M in Q2 2013. 1,673 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • Oakbrook Investments reported no remaining Eli Lilly position as of Q4 2019 after selling out during the quarter.
  • Oakbrook Investments sold 43,650 Eli Lilly shares in Q4 2019, an estimated $4.88M.
  • Oakbrook Investments first reported a position in Eli Lilly in Q2 2013 and held it in 22 quarters.
  • Oakbrook Investments's Eli Lilly position peaked at $10.4M in Q2 2013.
  • 1,673 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.